-
-
safety,quality,efficacy -
safety,quality,efficacy -
safety,quality,efficacy
provide users with high-quality blood products
-
2023/12/18some products of shanghai raas cancel the limited payment scope of medical insuranceview details
-
2023/03/01shanghai raas was re-awarded the title of "leading enterprise of oriental beauty valley".view details
-
-
2022/10/21"excellent! they are "shanghai pioneer workers"
-
2022/10/21congratulations on the official release of the blue book on the development and clinical application of blood products in china!
-
2022/05/05shanghai raas becomes the exclusive distributor of grifols nucleic acid testing solution in china
-
about raas
being vital for life saving, blood products are important national strategic reserve materials. founded in 1988 and situated at no. 2009 wangyuan road, fengxian district, shanghai with a registered capital of rmb 6,740,787,907.00, shanghai raas was listed on the shenzhen stock exchange in june 2008 as a leading domestic blood products company that integrates source plasma collection, blood products research and development, production and sales.
-
35 years extensive industry experience
-
4 units production bases
-
42 centers (including newly approved) plasma donation center
0.20 ( 3.13%)
raas plasma donation center
as of may 2023, shanghai raas and its subsidiaries had 42 plasma donation centers (including newly approved ) in china including those under construction, of which 18 are shanghai raas (including one subcenter) , 19 are tonrol biopharmaceutical (including newly approved) , 2 are zhengzhou raas and 3 are zhejiang haikang biopharmaceutical, covering 11 provinces (autonomous regions) in guangxi, hunan, hainan, shaanxi, anhui, guangdong, inner mongolia, zhejiang, hubei, jiangxi and shandong.
-
18 centers shanghai raas (including one subcenter)
-
19 centers tonrol biopharmaceutical
-
2 centers zhengzhou raas
-
3 centers zhejiang haikang biopharmaceutical
